Acadian Asset Management
XFOR icon

Acadian Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History

Acadian Asset Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3K Buy
+802
New +$3K ﹤0.01% 1992
2024
Q1 		– Sell
-6,054
Closed -$152K – 1817
2023
Q4 		$152K Buy
+6,054
New +$147K ﹤0.01% 1284
2022
Q1 		– Sell
-1,909
Closed -$130K – 1832
2021
Q4 		$130K Buy
+1,909
New +$241K ﹤0.01% 1328
2020
Q2 		– Sell
-68
Closed -$20K – 2359
2020
Q1 		$20K Buy
+68
New +$19.3K ﹤0.01% 1649
2018
Q4 		– Sell
-277
Closed -$81K – 1852
2018
Q3 		$81K Buy
+277
New +$117K ﹤0.01% 1259

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return